Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

MLA

Sormani, Maria Pia, et al. “Effect of SARS-CoV-2 MRNA Vaccination in MS Patients Treated with Disease Modifying Therapies.” EBioMedicine, vol. 72, Oct. 2021, p. 103581. EBSCOhost, https://doi.org/10.1016/j.ebiom.2021.103581.

APA

Sormani, M. P., Inglese, M., Schiavetti, I., Carmisciano, L., Laroni, A., Lapucci, C., Da Rin, G., Serrati, C., Gandoglia, I., Tassinari, T., Perego, G., Brichetto, G., Gazzola, P., Mannironi, A., Stromillo, M. L., Cordioli, C., Landi, D., Clerico, M., Signoriello, E., … Uccelli, A. (2021). Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies. EBioMedicine, 72, 103581. https://doi.org/10.1016/j.ebiom.2021.103581

Chicago

Sormani, Maria Pia, Matilde Inglese, Irene Schiavetti, Luca Carmisciano, Alice Laroni, Caterina Lapucci, Giorgio Da Rin, et al. 2021. “Effect of SARS-CoV-2 MRNA Vaccination in MS Patients Treated with Disease Modifying Therapies.” EBioMedicine 72 (October): 103581. doi:10.1016/j.ebiom.2021.103581.